Browse studies

Find your next paid study

4,350 recruiting studies matching your filters

Utilizing EndoPAT Device for Endothelial Dysfunction Assessment in Erectile Dysfunction and Hormonal Therapy

To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothel…

Erectile DysfunctionHypogonadism, MaleEndothelial Dysfunction

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, IrvineNCT06720597

Phase 1

A Phase Ia/Ib Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Including Patients With TP53 Mutations

The aim of PERKA-812-003 study is to investigate the safety, pharmacokinetics and preliminary anti-tumor activity of treatment with NMS-03597812 as single agen…

Relapsed/Refractory Acute Myeloid Leukemia

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Nerviano Medical SciencesNCT06549790

Coordination of Rare Diseases at Sanford

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, …

Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more

Phase 1

A Multicenter, Open-label Phase 1/2 Dose Finding, Safety, and Pharmacokinetic Study of MBRC-201, an Antibody-drug Conjugate, in Advanced Refractory Solid Tumors

This is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumor…

Prostate Cancer Castration-resistant Prostate CancerBreast CancerColo-rectal Cancer+2 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

MBrace TherapeuticsNCT07145255

Observational

Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)

This randomized Type 1 hybrid effectiveness-implementation trial (N=186) will evaluate the effectiveness and implementation of a peer-delivered problem solving…

HIV InfectionsSubstance Use

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Maryland, BaltimoreNCT06501781

Phase 1

Phase I, Open-Label Study of Autologous Mutant KRAS and ILT4-Redirected T-cell Receptor Cells (TCR1188-ABC)

This is a Phase I, open-label dose finding study to assess the safety, manufacturing feasibility, and preliminary efficacy of TCR1188-ABC cells in patients wit…

CholangiocarcinomaColorectal CancerNon-Small Cell Lung Cancer+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of PennsylvaniaNCT07594067

Phase 2

A Randomized Phase II Trial of Medical Cannabis to Reduce Symptom Burden in Patients With Advanced Pancreatic and Colorectal Cancer (CanPan-C)

Many patients with advanced pancreatic cancer and colorectal cancer experience burdensome and difficult-to-treat symptoms. The impact of multiple symptoms (cal…

Pancreatic Cancer Non-resectablePancreatic Cancer MetastaticColorectal Cancer Metastatic

Estimated

~$75 – $3,000

Actual pay is set by the research site.

HealthPartners InstituteNCT06605430

Phase 2

FORAY: A Phase 2, Randomized, Open-Label Study Evaluating Vepugratinib in Adults With FGFR3 Altered Low Grade, Intermediate Risk, Non-muscle Invasive Bladder Cancer and Low Grade Upper Tract Urothelial Carcinoma

The main purpose of this study is to see how well vepugratinib works in adults with low grade, intermediate risk, non-muscle invasive bladder cancer (LG IR NMI…

Urinary Bladder NeoplasmsUrologic NeoplasmsReceptor, Fibroblast Growth Factor, Type 3

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Eli Lilly and CompanyNCT07827612

Observational

Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients (APOYO): A Community Health Worker Intervention for Latinx Colorectal Cancer Patients

This study is a pilot feasibility randomized trial involving newly diagnosed colorectal cancer (CRC) patients who identify as Latinx. The study aims to leverag…

Colorectal Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Stanford UniversityNCT07403981

Phase 2

A Phase II Study of Combination Epcoritamab-Lenalidomide in Patients With Refractory/Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

This phase II trial tests how well the combination of epcoritamab and lenalidomide work in treating patients with immunodeficiency-related large B-cell lymphom…

Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Polymorphic Post-Transplant Lymphoproliferative DisorderRefractory B-Cell Non-Hodgkin Lymphoma

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Reem KarmaliNCT06723457

Phase 4

Outcomes of Tranexamic Acid With Anticoagulants in Orthopaedic Trauma Procedures: A Prospective Study

Tranexamic acid, an anti-fibrinolytic agent, is commonly given after induction of general anesthesia in patients undergoing hip and knee arthroplasty. This med…

Patients Undergoing Operative Fixation of Long Bone Fractures Within the Community Medical Centers System

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Arbi Nazarian, MDNCT07116395

Observational

Pilot Study to Test Effects of a New Interparental Conflict Intervention for Separating or Divorcing Parents

This pilot study will evaluate a new intervention for parents who are separated or divorced and have been court ordered to participate in a program addressing …

Interparental ConflictChild Mental Health

Estimated

~$10 – $750

Actual pay is set by the research site.

Arizona State UniversityNCT07816445